lead cross-functional and cross-regional integration efforts to ensure alignment and operational efficiency across the Rare Disease & Cardiometabolic CBU
develop and oversee long-term strategies aligned with product lifecycle stages
manage distributor relationships, ensuring adherence to service levels and effective delivery to international markets
monitor and analyze key industry trends, category data, and brand performance metrics to inform strategic decisions
drive lifecycle management initiatives and influence the strategic direction for commercialized products and pipeline assets
Requirements
at least 12+ years of progressive experience in life science strategy or business management consulting
4–6+ years in the pharmaceutical/biopharmaceutical market, including rare disease experience
a strong background in brand marketing, business development, or commercial operations
advanced degrees (e.g., PhD, MD, MBA) and experience in ultra-rare disease, franchise marketing, and product launches strongly preferred
Benefits
health and wellness programs (including medical, dental, vision, life, and disability insurance)